Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD1 | P21728 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD5 | P21918 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | GPR3 | P46089 | 1/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29767754 | 1.00 | DRD2 (0.49) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL15595295 | 0.96 | DRD2 (0.49) | DRD2DRD1DRD4DRD5DRD3 | |
| Ammonia Solution, Strong SCHEMBL15466738 | 0.85 | DRD2 (0.50) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL29292345 | 0.85 | ALDH1A1 (0.44) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL15180554 | 0.80 | GPR3 (0.39) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL18866963 | 0.80 | GPR3 (0.39) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL25294084 | 0.79 | DRD2 (0.45) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL30439522 | 0.79 | DRD2 (0.45) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL30439911 | 0.78 | DRD2 (0.42) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL11881666 | 0.78 | DRD2 (0.42) | DRD2DRD1DRD4DRD5DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861128-A | Polymerizable compound and optically anisotropic body | 江苏创拓新材料有限公司 | 2021-12-31 | — | — | CN | claimed |
| EP-1852420-B1 | Indole compounds for treating respiratory disorders | ONO PHARMACEUTICAL CO (JP) | 2012-10-17 | — | — | EP | claimed |
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| US-20260083735-A1 | ABHD6 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4642875-A1 | A PROCESS AND PLANT FOR DESULFURIZING A CRUDE HYDROCARBON COMPOSITION, SUCH AS DIESEL OR KEROSINE | Sulzer Management AG (CH) | 2025-11-05 | — | — | EP | disclosed |
| EP-4596555-A1 | ABHD6 ANTAGONIST | ONO Pharmaceutical Co., Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-12275897-B2 | Boron doped hydrodesulfurization catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-04-15 | — | — | US | disclosed |
| US-12275898-B2 | Hydrodesulfurization reaction composition | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-04-15 | — | — | US | disclosed |
| US-12275899-B2 | MOCO hydrodesulfurization catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-04-15 | — | — | US | disclosed |
| CN-119524885-A | Preparation and application of egg yolk-shell structure phase hydrodesulfurization catalyst based on hydrogen overflow | 中国石油大学(华东) | 2025-02-28 | — | — | CN | disclosed |
| US-20250063948-A1 | HIGH EFFICIENCY AND LONG LIFETIME ORGANIC LIGHT-EMITTING DIODE | SFC CO., LTD. (KR) | 2025-02-20 | — | — | US | disclosed |
| US-5186818-A | Hydrodesulfurizatioin and/or hydrodenitrogenation using transition metal compounds in stacked beds having controlled rim to edge ratios | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1993-02-16 | — | — | US | disclosed |
| US-4544481-A | HYDROTREATMENT OF HYDROCARBONS | EXXON RESEARCH AND ENGINEERING CO. (US) | 1985-10-01 | — | — | US | disclosed |
| US-4542121-A | Catalysts from molybdenum polysulfide precursors, their preparation and use | EXXON RESEARCH AND ENGINEERING CO. (US) | 1985-09-17 | — | — | US | disclosed |
| US-4540481-A | HYDROCARBON HYDROTREATMENT | EXXON RESEARCH AND ENGINEERING CO. (US) | 1985-09-10 | — | — | US | disclosed |
| US-4457836-A | FROM PETROLEUM DISTILLATES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-07-03 | — | — | US | disclosed |
| US-4431747-A | HYDROREFINING CATALYSTS; METHANATION; HYDROTREATMENT; IMPREGNATING WITH A ORGANIC AMINE METAL COMPLEX | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-02-14 | — | — | US | disclosed |
| US-4430442-A | HYDROREFINING CATALYSTS; CATALYST SELECTIVETY; HYDRODENITROGENIZATION | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-02-07 | — | — | US | disclosed |
| US-4334078-A | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIRHEUMATICS | HOFFMANN-LA ROCHE INC. (US) | 1982-06-08 | — | — | US | disclosed |
| US-4219657-A | USED AS ANTIINFLAMATORY AGENTS, ANALGESICS, ANTIRHEUMATIC AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1980-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ABHD6, ABHD16A, HDHD5 | DRD2 1933/4885DRD1 2073/4885DRD4 2694/4885 |
| US-20260083735-A1 | ABHD6 ANTAGONIST | ABHD6, ABHD16A, ABHD12 | DRD2 1517/4885DRD1 2604/4885DRD4 2397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.